[1]
Restrepo Valencia, C.A., Chacón, J.A. and Ospina Jiménez, J.I. 2023. Hyperpotassemia secondary to the combined use of an ACEI or ARB II with spironolactone. Revista de Nefrología, Diálisis y Trasplante. 43, 04 (Dec. 2023), 228-235.